Literature DB >> 28478618

Regional versus local anesthesia for arteriovenous fistula creation in end-stage renal disease: a systematic review and meta-analysis.

Ammar Ismail1,2,3, Abdelrahman Ibrahim Abushouk2,4, Amira H Bekhet3,5, Osama Abunar6, Omar Hassan7, Ahmed A Khamis8, Mohamed Al-Sayed8, Ahmed Elgebaly1.   

Abstract

There is a consensus in the literature that regional anesthesia (RA) improves local hemodynamic parameters in comparison to local anesthesia (LA) during arteriovenous fistula (AVF) surgical construction. However, the effects of both techniques on fistula patency and failure rates are still controversial. The aim of this meta-analysis is to synthesize evidence from published randomized trials and observational studies regarding the safety and efficacy of RA versus LA in AVF surgical construction. A computer literature search of PubMed, Scopus, Web of Science, and Cochrane Central retrieved six randomized trials (462 patients) and one retrospective study (408 patients). Pooling data using RevMan software (version 5.3) showed that RA was superior to LA in terms of primary fistula patency rate (RR = 1.22, 95% CI [1.08, 1.37], p = 0.0010); however, both types were comparable in terms of primary fistula failure rate (RR = 0.81, 95% CI [0.47, 1.40], p = 0.46). In comparison to LA, RA was associated with improved hemodynamic parameters including fistula blood flow (MD = 25.08, 95% CI [19.40, 30.76], p<0.00001), brachial artery diameter (SMD = 2.63, 95% CI [2.17, 3.08], p<0.00001), and outflow venous diameter (SMD = 0.93, 95% CI [0.30, 1.75], p = 0.004). Postoperative complications were comparable between both groups (OR = 0.23, 95% CI [0.05, 0.97], p = 0.05). In conclusion, RA was associated with higher primary patency rates of AVF and improved local blood flow in comparison to LA; however, both procedures were comparable in terms of primary failure rates and postoperative complications. Larger well-designed trials with longer follow-up periods should compare both techniques in terms of long-term patency rates and safety outcomes.

Entities:  

Mesh:

Year:  2017        PMID: 28478618     DOI: 10.5301/jva.5000683

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  6 in total

1.  Long-Term Functional Patency and Cost-Effectiveness of Arteriovenous Fistula Creation under Regional Anesthesia: a Randomized Controlled Trial.

Authors:  Emma Aitken; Rachel Kearns; Lucian Gaianu; Andrew Jackson; Mark Steven; John Kinsella; Marc Clancy; Alan Macfarlane
Journal:  J Am Soc Nephrol       Date:  2020-07-24       Impact factor: 10.121

2.  Anesthetic choice for arteriovenous access creation: A National Anesthesia Clinical Outcomes Registry analysis.

Authors:  Kaitlin Woods; Samantha D Minc; Dylan Thibault; Jacob Lambert; Amaris Jalil; Luke Marone; Matthew Ellison; Jw Awori Hayanga; Heather K Hayanga
Journal:  J Vasc Access       Date:  2021-09-21       Impact factor: 2.326

3.  Sympatholytic and Anti-Inflammatory Effects of Ropivacaine and Bupivacaine After Infraclavicular Block in Arterio Venous Fistula Surgery.

Authors:  Faranak Behnaz; Pardis Soltanpoor; Houman Teymourian; Niki Tadayon; Gholam Reza Mohseni; Mahshid Ghasemi
Journal:  Anesth Pain Med       Date:  2019-02-10

4.  Clinical Observation of Patients Undergoing Glioma Surgery under Propofol and Sevoflurane Anesthesia: A Retrospective Study.

Authors:  Junbiao Fang; Hongfa Wang; Weihua Zhang; Kaichuang Yang; Weiyu Wang
Journal:  J Oncol       Date:  2022-06-08       Impact factor: 4.501

5.  Radiocephalic Arteriovenous Fistula Patency and Use: A Post Hoc Analysis of Multicenter Randomized Clinical Trials.

Authors:  Patrick Heindel; Peng Yu; Jessica D Feliz; Dirk M Hentschel; Steven K Burke; Mohammed Al-Omran; Deepak L Bhatt; Michael Belkin; C Keith Ozaki; Mohamad A Hussain
Journal:  Ann Surg Open       Date:  2022-08-23

6.  Comparison of regional and local anesthesia for arteriovenous fistula creation in end-stage renal disease: a systematic review and meta-analysis.

Authors:  Chen Gao; Chunyan Weng; Chenghai He; Jingli Xu; Liqiang Yu
Journal:  BMC Anesthesiol       Date:  2020-08-31       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.